Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by NPR. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NPR or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Can doctors test embryos for autism? And should they?

23:06
 
Share
 

Manage episode 485395332 series 1463155
Content provided by NPR. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NPR or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These conditions are informed by many genetic variants and environmental factors - so companies like Orchid and Heliospect assign risk scores to each embryo for a given condition. These tests are expensive, only available through IVF, and some researchers question how these risk scores are calculated. But what would it mean culturally if more people tried to screen out some of these conditions? And how does this connect to societal ideas about whose lives are meaningful?
Brittany gets into it with Vardit Ravitsky, senior lecturer at Harvard Medical School and president of the Hastings Center, a non-partisan bioethics research center, and Katie Hasson, associate director of the Center for Genetics and Society, a nonprofit public affairs organization that advocates for responsible use of genetic technology.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
  continue reading

1029 episodes

Artwork
iconShare
 
Manage episode 485395332 series 1463155
Content provided by NPR. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NPR or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These conditions are informed by many genetic variants and environmental factors - so companies like Orchid and Heliospect assign risk scores to each embryo for a given condition. These tests are expensive, only available through IVF, and some researchers question how these risk scores are calculated. But what would it mean culturally if more people tried to screen out some of these conditions? And how does this connect to societal ideas about whose lives are meaningful?
Brittany gets into it with Vardit Ravitsky, senior lecturer at Harvard Medical School and president of the Hastings Center, a non-partisan bioethics research center, and Katie Hasson, associate director of the Center for Genetics and Society, a nonprofit public affairs organization that advocates for responsible use of genetic technology.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
  continue reading

1029 episodes

Alle Folgen

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play